Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Rivaroxaban'

Rivaroxaban published presentations and documents on DocSlides.

Rivaroxaban compared with enoxaparin for the prevention of
Rivaroxaban compared with enoxaparin for the prevention of
by luanne-stotts
Alexander T Cohen . On behalf of the MAGELLAN Ste...
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:
Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:
by giovanna-bartolotta
Rivaroxaban Plus Aspirin in Patients With and Wit...
Recent ACS: STEMI, NSTEMI, UA
Recent ACS: STEMI, NSTEMI, UA
by danika-pritchard
Stabilized 1-7 Days Post-Index Event. Exclusions:...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Novel Oral Anticoagulants
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
R eal-world
R eal-world
by liane-varnes
EVI. dence. on . S. troke prevention . I. n pati...
New Oral Anticoagulant
New Oral Anticoagulant
by mitsue-stanley
R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Stroke, Bleeding, and
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
CAD/PAD in Primary Care CV Risk in Stable Outpatients
CAD/PAD in Primary Care CV Risk in Stable Outpatients
by stefany-barnette
Stratified by Baseline CV Risk Category. Aspirin ...
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
A ssessment of D ual antiplatelet therapy versus
A ssessment of D ual antiplatelet therapy versus
by stefany-barnette
A ssessment of D ual antiplatelet therapy versus...
Ima A. Kusuma , MD, FIHA
Ima A. Kusuma , MD, FIHA
by hirook
“JIH. ” Hospital, Yogyakarta, Indonesia. The U...
A ssessment of D ual antiplatelet therapy versus
A ssessment of D ual antiplatelet therapy versus
by coursion
R. ivaroxaban . I. n atrial . F. ibrillation patie...
Rivaroxaban in stable peripheral or carotid artery disease
Rivaroxaban in stable peripheral or carotid artery disease
by basidell
Sonia Anand, on . behalf of the COMPASS Steering C...
Thromboembolic protocols
Thromboembolic protocols
by cecilia
& safe anticoagulant prescribing. July 2020. D...
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
by HoneyBun
VTE death. ) for . rivaroxaban. vs. . enoxaparin....
Review on NOACs Studies Dr.
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
by kyle585
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
Update on the New Oral Anticoagulants
Update on the New Oral Anticoagulants
by sherrill-nordquist
Eliot Williams, MD PhD. Division of Hematology &a...
Alexander G
Alexander G
by min-jolicoeur
G. . Turpie. Professor Emeritus of Medicine. McM...
Management of
Management of
by marina-yarberry
Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...
Oral anticoagulants in the 21
Oral anticoagulants in the 21
by natalia-silvester
st. century: A practical guide to using newer A...
Dodson Thompson, DO
Dodson Thompson, DO
by lois-ondreau
Northlakes. Community Clinic. Minong, WI. Novel ...
Update in the Perioperative and Emergency Management of Nov
Update in the Perioperative and Emergency Management of Nov
by danika-pritchard
Annelise Gallien, MD FRCPC. Moncton City Hospital...
The Novel Oral Anticoagulants
The Novel Oral Anticoagulants
by tatyana-admore
Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...
Trials and Tribulations in VTE:
Trials and Tribulations in VTE:
by celsa-spraggs
How Do Real-World Data Fit In? . Program Goals. V...
Pharmaceutical Management of Cardiac Medications:
Pharmaceutical Management of Cardiac Medications:
by pamella-moone
A Look at New Oral Anticoagulants. Linda Wing, . ...
Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage
Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage
by faustina-dinatale
Fred V. Plapp MD PhD. Pathology and Laboratory Me...
Sandy Bartlett, PhD, PharmD
Sandy Bartlett, PhD, PharmD
by mitsue-stanley
, . BCPS, BCCCP. Associate Professor | Department...
POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF
POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF
by phoebe-click
NOACS IN AF. Where Do We Stand With NOACs in AF ...
New Oral Anticoagulants: A Review
New Oral Anticoagulants: A Review
by phoebe-click
Babak Moini, MD. Veterans Affairs Hospital. Noon ...
Pharmacology of Anticoagulants
Pharmacology of Anticoagulants
by conchita-marotz
Nathan Culver, . PharmD. , BCPS. anticoagulant Me...
Anticoagulation and Thrombosis Management
Anticoagulation and Thrombosis Management
by pasty-toler
Anticoagulation and Thrombosis Management A Revie...
Bleeding and cancer risk in patients with vascular
Bleeding and cancer risk in patients with vascular
by danika-pritchard
Bleeding and cancer risk in patients with vascul...